Is Sarepta Therapeutics Inc (NASDAQ: SRPT) Back In The Buying Zone?

Currently, there are 98.25M common shares owned by the public and among those 93.39M shares have been available to trade. The company’s stock has a 5-day price change of 10.47% and -62.67% over the past three months. SRPT shares are trading -67.11% year to date (YTD), with the 12-month market performance down to -69.87% lower. […]

Sarepta Therapeutics Inc (NASDAQ: SRPT) Has Another Chance To Impress You

Currently, there are 96.90M common shares owned by the public and among those 92.29M shares have been available to trade. The company’s stock has a 5-day price change of -23.17% and -59.02% over the past three months. SRPT shares are trading -61.55% year to date (YTD), with the 12-month market performance down to -64.21% lower. […]

Sarepta Therapeutics Inc (NASDAQ: SRPT): The Best-Of-Breed For Investing?

The Vanguard Group, Inc. recently announced the acquisition of new stake in Sarepta Therapeutics Inc (NASDAQ:SRPT). The institutional investor has increased its shareholding in the Healthcare company by 0.46% to 8.45 million shares with purchase of 38383.0 shares. This fresh investment now brings its stake to 9.03% valued currently at $686.45 million. In addition, Janus […]

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.